Ghost Tree Capital as of Dec. 31, 2018
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 36 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 22.7 | $65M | 750k | 87.00 | |
| Immunomedics | 7.9 | $23M | 1.6M | 14.27 | |
| Mirati Therapeutics | 5.9 | $17M | 400k | 42.42 | |
| Dicerna Pharmaceuticals | 4.7 | $13M | 1.3M | 10.69 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.6 | $13M | 80k | 165.71 | |
| Retrophin | 3.9 | $11M | 500k | 22.63 | |
| Biohaven Pharmaceutical Holding | 3.5 | $10M | 275k | 36.98 | |
| Anaptysbio Inc Common (ANAB) | 3.1 | $8.9M | 140k | 63.79 | |
| Rocket Pharmaceuticals (RCKT) | 3.1 | $8.9M | 600k | 14.82 | |
| Iovance Biotherapeutics (IOVA) | 3.1 | $8.9M | 1.0M | 8.85 | |
| Kalvista Pharmaceuticals (KALV) | 2.9 | $8.4M | 425k | 19.75 | |
| Ascendis Pharma A S (ASND) | 2.7 | $7.8M | 125k | 62.65 | |
| Sarepta Therapeutics (SRPT) | 2.7 | $7.6M | 70k | 109.13 | |
| Global Blood Therapeutics In | 2.6 | $7.6M | 185k | 41.05 | |
| Obseva Sa | 2.4 | $7.0M | 550k | 12.66 | |
| Audentes Therapeutics | 2.2 | $6.4M | 300k | 21.32 | |
| Amicus Therapeutics (FOLD) | 2.2 | $6.2M | 650k | 9.58 | |
| Tricida | 2.0 | $5.9M | 250k | 23.58 | |
| Invesco exchange traded (FXF) | 1.8 | $5.2M | 55k | 94.87 | |
| Orchard Therapeutics Plc ads | 1.6 | $4.7M | 300k | 15.73 | |
| Viewray (VRAYQ) | 1.6 | $4.6M | 750k | 6.07 | |
| Kadmon Hldgs | 1.4 | $4.2M | 2.0M | 2.08 | |
| BioCryst Pharmaceuticals (BCRX) | 1.4 | $4.0M | 500k | 8.07 | |
| BioDelivery Sciences International | 1.3 | $3.7M | 1.0M | 3.70 | |
| Zafgen | 1.3 | $3.7M | 750k | 4.95 | |
| Momenta Pharmaceuticals | 1.2 | $3.6M | 325k | 11.04 | |
| Sage Therapeutics (SAGE) | 1.1 | $3.2M | 33k | 95.76 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $2.6M | 35k | 72.91 | |
| Arvinas Ord (ARVN) | 0.8 | $2.2M | 175k | 12.85 | |
| ACADIA Pharmaceuticals (ACAD) | 0.7 | $2.0M | 125k | 16.17 | |
| Urovant Sciences | 0.7 | $2.0M | 300k | 6.59 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $1.6M | 79k | 20.00 | |
| Catalyst Biosciences | 0.6 | $1.6M | 200k | 7.89 | |
| Genocea Biosciences | 0.4 | $1.0M | 3.5M | 0.29 | |
| Proteostasis Therapeutics In | 0.2 | $616k | 190k | 3.24 | |
| Motus Gi Hldgs Incorporated | 0.1 | $311k | 100k | 3.11 |
